Westinghouse Releases New Report on Economic Impact of AP1000 ® Deployment in Poland & Down Selects Key Polish Suppliers
Today, Westinghouse Electric Company released an independent report from PricewaterhouseCoopers LLC (PwC) outlining the considerable economic footprint of deploying six AP1000® units in Poland.
The study projects the manufacturing, engineering and construction phase of six AP1000 units will produce more than PLN 118.3 billion of Gross Domestic Product (GDP) impact and over 120,000 person-years of direct employment in-country. Once operational, these units will create a minimum of PLN 38 billion in GDP and support 16,300 jobs annually.
The Polish project is being implemented by Polskie Elektrownie Jądrowe, a company owned by the Polish state, which is responsible for implementation and execution of the Polish Nuclear Energy Program (PPEJ). The Program will deliver safe and reliable Generation III+ pressurized water reactors – the first three will be built using AP1000 technology at the Lubiatowo-Kopalino location in the Pomerania region.
Westinghouse also announced the down selection of seven Polish suppliers to support the Lubiatowo-Kopalino site and other European projects: Polimex Mostostal Siedlce, Baltic Operator (Grupa Przemyslowa Baltic), Mostostal Kielce, Mostostal Krakow, ZKS Ferrum, Famak and Energomontaz-Polnoc Gdynia. The down selection process was conducted in a transparent and competitive manner, considering requirements of quality assurance applicable to nuclear island equipment. This is a part of the process of preparation for the execution phase of the project in Lubiatowo-Kopalino.
“Deploying our AP1000 technology in Poland represents a 100-year partnership between the United States and Poland on energy security,” said David Durham, President of Westinghouse Energy Systems. “This study further underlines the significant and long-term economic, human capital and climate benefits that this technology can provide for the country, its people and deeply experienced supply chain. The involvement of leading suppliers like those we announced today will be critical as Westinghouse advances this visionary nuclear power plant project.”
Further findings detailed in the PwC study include:
- AP1000 technology supports the EU target of achieving net-zero greenhouse gas emissions by 2050. The project will generate a 39% reduction in CO2 emissions compared to existing power generation, while providing over 13 million homes with carbon-free energy.
- It will establish a highly skilled nuclear workforce through leadership training and partnerships with local, higher education institutes. Once operational, the AP1000 project would also aid in the training of more than 2,400 local employees.
- The country’s supply chain can support new global AP1000 deployments, generating an additional PLN 1.9 billion in GDP per unit. Additional opportunities will also be available with eVinci™ microreactor and AP300™ Small Modular Reactor deployments in Europe.
The AP1000 reactor is the only operating Generation III+ reactor with fully passive safety systems, modular construction design and the smallest footprint per MWe on the market. In the U.S., at the Vogtle site in Georgia, one AP1000 unit achieved commercial operation in July 2023 and is producing power for the grid, while a second unit recently achieved initial criticality with commercial operation projected during the second quarter of 2024. Four AP1000 reactors are currently setting operational performance and availability records in China with eight additional reactors under construction. Ukraine has made firm commitments for nine AP1000 units, and Bulgaria selected the AP1000 technology for two units at the Kozloduy nuclear site. The technology is also under consideration at multiple other sites in Central and Eastern Europe, the United Kingdom, India and North America.
Download the full report – The Economic Impact of a Westinghouse AP1000 Reactor Project in Poland – here.
Westinghouse Electric Company is shaping the future of carbon-free energy by providing safe, innovative nuclear and other clean power technologies and services globally. Westinghouse supplied the world’s first commercial pressurized water reactor in 1957 and the company’s technology is the basis for nearly one-half of the world's operating nuclear plants. Over 135 years of innovation makes Westinghouse the preferred partner for advanced technologies covering the complete nuclear energy life cycle. For more information, visit www.westinghousenuclear.com and follow us on Facebook, LinkedIn and X.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409679044/en/
Contact information
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
